Finch Therapeutics Group, Inc. FNCH
Aug 5, 2026, 3:47 PM EDT
52-week range unavailable
- YTD
- -24.39%
- 1 year
- -25.17%
- Market cap
- 16.38M
- Shares out
- 1.61M
- Forward P/E
- -0.07
- YTD return
- -24.39%
- 1-year return
- -25.17%
- Volume
- 868
- Open
- 10.00
- Previous close
- 10.20
- Day's range
- 10.00 – 10.20
- Beta
- 0.26
- Analysts
- Buy
- Earnings date
- Dec 25, 2024
1Y -6.63 (-47.09%)
Key statistics
- Enterprise value
- 10.86M
- PEG ratio
- 0.00
- Price / book
- 0.12
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -20.34M
- Total cash
- 20.76M
- Total debt
- 29.56M
- Return on equity
- -62.64%
- Short % of float
- 2.76%
- 50-day average
- 1.94
- 200-day average
- 3.24
Analyst view
Consensus: buy
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Dec 25, 2024
Expected Dec 25, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 25, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -3.01 | — | — |
| May 10, 2024 | Mar 1, 2024 | 0.00 | -2.41 | — | — |
| Mar 25, 2024 | Dec 1, 2023 | 0.00 | -1.89 | — | — |
| Nov 8, 2023 | Sep 1, 2023 | 0.00 | -1.51 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -4.51 | -4.33 | +0.18 | +3.99% |
About Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- finchtherapeutics.com
News
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Tuesday - Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Friday - Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Stocks That Hit 52-Week Lows On Wednesday
Your note
Sign in to keep a note on FNCH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLAUSTEIN MARC | Chief Operating Officer | Sale | Feb 20, 2023 | 27,995 |
| CRESTOVO INVESTOR, L.L.C. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 22, 2021 | 0 |
| FERRANTE DOMENIC J | Director | Purchase | Mar 22, 2021 | 0 |
| GRAF SUSAN E | Director | Purchase | Jun 8, 2023 | 5,010 |
| HAFT NICHOLAS | Director | Purchase | Dec 19, 2021 | 0 |
| SMISEK JEFFERY A | Director | Stock Gift | Jun 6, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baupost Group, Inc,.(The) LLC | 4.19% | 67,296 | 574.03K | Jun 29, 2023 |
| Susquehanna International Group, LLP | 3.68% | 59,028 | 503.51K | Jun 29, 2023 |
| Avenir Management Company, LLC | 3.46% | 55,445 | 472.94K | Jun 29, 2023 |
| Vanguard Group Inc | 2.04% | 32,676 | 278.73K | Jun 29, 2023 |
| Lake Street Advisors Group, LLC | 1.32% | 21,206 | 180.89K | Jun 29, 2023 |
| Ikarian Capital, LLC | 0.49% | 7,917 | 67.53K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.78% | 28,528 | 243.34K | Jun 29, 2023 |
| Collaborative Inv Ser Tr-Greenwich Ivy Long-Short Fd | 0.47% | 7,497 | 63.95K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.26% | 4,148 | 35.38K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.23% | 3,713 | 31.19K | May 30, 2023 |
| DFA U.S. Targeted Value Portfolio | 0.21% | 3,378 | 25.88K | Jul 30, 2023 |
| Fidelity Total Market Index Fund | 0.10% | 1,608 | 13.51K | May 30, 2023 |